Medical/Pharmaceuticals News & Press Release Distribution

Diana Bracco: "Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses"

MILAN, Sept. 21, 2023 /PRNewswire/ -- Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence is the title describing the theme of the 2023 edition of Bracco Innovation Day. This event took place at the Human ...

2023-09-21 01:47 2353

European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * ORSERDU is the first treatment specifically for patients with ER+, HE...

2023-09-20 23:27 2385

Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist

HONG KONG and NANJING, China, Sept. 20, 2023 /PRNewswire/ -- Hepagene Therapeutics, Inc. a clinical-stage biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for its HPG7233, an agonist of Thyroid H...

2023-09-20 22:00 1503

Taiwan's Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health

NISORO HEALTH introduces high-quality Pineapple Enzyme, a digestive elixir blendingTaiwan's pineapples and LJ88 probiotics. It enhances digestion, promotes gut health, and is suitable for all ages. TAIPEI, Sept. 20, 2023 /PRNewswire/ -- Taiwan is renowned for its exceptional products, and NISORO...

2023-09-20 21:00 1590

Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies

News Summary: * New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. * Measures biologic drug products at extremely low sample volume...

2023-09-20 20:00 2227

Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Sanyou Bio's consecutive wins reflect our clients' trust, and our proven track record, raising expectations for our future. This recognition from peers and industry experts motivate us to remain committed to our mission, and to consistently provide high-qu...

2023-09-20 20:00 1350

WuXi XDC Launches New Commercial Manufacturing Facilities

* New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product * Doubled capacity provides greater support to the rapidly growing global bioconjugate industry WUXI, China, Sept. 20, 2023 /PRNewswire/ -- WuXi XDC, a ...

2023-09-20 18:51 1629

The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, has announced that the multinatio...

2023-09-20 15:52 1747

AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmologic, neurological and psychiat...

2023-09-20 09:00 2556

Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines inGreater China and other parts of Asia, announced today that the Center for Drug E...

2023-09-20 08:26 1997

Hospital Clinica Biblica Joins Global Provider Network to Transform Healthcare in Costa Rica

WEST PALM BEACH, Fla., Sept. 20, 2023 /PRNewswire/ -- Hospital Clinica Biblica, the largest private hospital inCosta Rica, has joined the Global Provider Network (GPN), a step that widens access to affordable and world-class healthcare offerings inCosta Rica for American consumers and self-funded...

2023-09-20 03:58 1748

New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda

WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- Seventeen patient advocacy organizations from North andSouth America, Europe, Asia and the Middle East have formed theGlobal Patient Alliance for Kidney Health. The Alliance aims to elevate patient voices and advocate for policies that enhance access to ...

2023-09-20 00:00 1668

Verista Awarded by Frost & Sullivan for Providing Next-Generation Compliance and Quality Management Solutions in the Life Sciences Industry

Verista supports its clients by implementing pioneering services, solutions and technologies, along with its unwavering client commitment and deep domain expertise SAN ANTONIO, Sept. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the life sciences quality management and compliance...

2023-09-19 21:00 1436

Verista Awarded by Frost & Sullivan for Providing Next-Generation Compliance and Quality Management Solutions in the Life Sciences Industry

Cerecin strengthens position in neurometabolism with addition to pipeline

* Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and usein positron emission tomography (PET) studies of ketone body metabolism * Company expands ketogenic platform following pilot data of CER-0001 in migraine and infantile spasms. ...

2023-09-19 19:39 1765

Neusoft Holds the Top Market Share of Medical Imaging Information System in China

SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022", in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continu...

2023-09-19 17:00 1864

Clarivate Unveils Citation Laureates 2023 - Annual List of Researchers of Nobel Class

71 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON, Sept. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today na...

2023-09-19 15:00 1726

Neusoft Holds the Top Market Share of Medical Imaging Information System in China

SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022", in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continu...

2023-09-19 14:25 2058

Ceva Santé Animale launches the 2024 edition of its "Call for Projects" to help advance the human-animal bond

LIBOURNE, France, Sept. 19, 2023 /PRNewswire/ -- After the success of its first European edition last year, Ceva Santé Animale (Ceva), the #5 global animal health company, present in 110 countries worldwide, is pleased to announce the launch of its highly anticipated2024 "Call for Projects". This...

2023-09-19 13:05 2157

Ceva Santé Animale launches the 2024 edition of its

Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment

TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focusing on breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics, announced the completion of subject recruitment in the CBL-0201EFP Phase 2-stage...

2023-09-19 11:16 1307

ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand...

2023-09-19 09:16 2028